The Year in Cardiovascular Medicine 2020: Acute Coronary Syndromes and Intensive Cardiac Care

Borja Ibanez; David Roque; Susanna Price


Eur Heart J. 2021;42(9):884-895. 

In This Article

Abstract and Introduction


Graphical Abstract

Highlights of 2020 publications on acute cardiac care–acute coronary syndromes. The statements in this figure are based on individual published articles and do not represent any kind of recommendation. ACS, acute coronary syndrome; CABG, coronary artery bypass grafting; COVID-19, coronavirus disease 19; DAPT, dual antiplatelet therapy; FFR, fractional flow reserve; I/R, ischaemia–reperfusion; IRA, infarct-related artery; MI, myocardial infarction; MINOCA, myocardial infarction with non-obstructive coronary arteries; MVD, multivessel disease; MVO, microvascular obstruction; NSTE-ACS, non-ST segment elevation acute coronary syndrome; PCI, percutaneous coronary intervention; SARS-CoV2, severe acute respiratory syndrome coronavirus 2; SCAD, spontaneous coronary artery dissection; STEMI, ST-segment elevation myocardial infarction; 4UDMI, fourth universal definition of myocardial infarction. Numbers correspond to the references in the text.


Advancements in acute cardiac care have significantly contributed to prolonging life expectancy and improving quality of care. Acute cardiac care is an area of intense basic, translational, and clinical research. In particular, acute coronary syndrome (ACS) is one of the most frequent clinical presentations requiring acute cardiac care. Despite improvements in primary prevention, the incidence of ACS and its associated mortality and morbidity remains high, with an immense impact on patients and healthcare systems. This review presents the most relevant publications in 2020 that are likely to impact on the clinical management of patients presenting with ACS requiring intensive cardiac care.